
Opinion|Videos|June 4, 2024
Defining the Standard of Care for Early Breast Cancer Treatment
Heather Moore, BCOP, CPP, PharmD, discusses the importance of treatment for early breast cancer, highlighting the use of chemotherapy followed by endocrine therapy. She notes that CDK4/6 inhibitors are being added for higher-risk patients, and oral selective estrogen receptor degraders may also be used in advanced cases.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Experimental Multistage Malaria Vaccine Demonstrates Promising Protection in Early Trial
2
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
3
A Healthy Gut Could Improve Mental Health
4
FDA Approves First Oral GLP-1 for Weight Management
5












































































































































































































